COVID-19 InfectionNCT04848610
The Factors That Affect the Infection of COVID-19
An observational study of COVID-19 Infection, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
Trial summary
The number of new Coronavirus-2019 (Covid-19) cases is increasing day by day despite the warnings "Stay at home! Wear a mask! Keep social distance!". The aim of this descriptive study is to determine the risk factors that affect the Covid-19 infection in Turkey. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- COVID-19 Infection
- How many people
- 1,104 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 18 Oct 2020to 25 Feb 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The majority of the lands within the Republic of Turkey cover Anatolia, while a minor part covers Thrace, the southeast extension of the Balkan Peninsula. The population of Turkey is 83,154,997. Based on the natural, human and financial characteristics, the country consists of seven regions: Mediterranean, Eastern Anatolia, Aegean, Southeastern Anatolia, Central Anatolia, Marmara, and Black Sea. The majority of the population lives in the Marmara Region. Many people from seven regions of Turkey were invited to participate in the study, only 1264 individuals participated. The data of 1104 people who agreed to participate and completed the assessment form thoroughly were included. Data of 160 were excluded owing to answering certain items twice.
Who may be able to join
- Being over the age of 18
- Be in good mental and mental health
- To be able to read and write
Who cannot join
- Being under the age of 18
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Istanbul University-Cerrahpasa Florence Nightingale Nursing Faculty
Istanbul, 34854
About this study
Official title: Evaluation of The Factors That Affect The Infection Of Covid-19 In Turkish Society
The number of new Coronavirus-2019 (Covid-19) cases is increasing day by day despite the warnings "Stay at home! Wear a mask! Keep social distance!". The aim of this descriptive study is to determine the risk factors that affect the Covid-19 infection in Turkey.
The online link of the form created on Google forms was sent to the participants' phones between 18.10.2020 and 18.11.2020.
Read the detailed description
The number of new Coronavirus-2019 (Covid-19) cases is increasing day by day despite the warnings "Stay at home! Wear a mask! Keep social distance!". The aim of this descriptive study is to determine the risk factors that affect the Covid-19 infection in Turkey.
The majority of the lands within the Republic of Turkey cover Anatolia, while a minor part covers Thrace, the southeast extension of the Balkan Peninsula. The population of Turkey is 83,154,997. Based on the natural, human and financial characteristics, the country consists of seven regions: Mediterranean, Eastern Anatolia, Aegean, Southeastern Anatolia, Central Anatolia, Marmara, and Black Sea. The majority of the population lives in the Marmara Region. The online link of the form created on Google forms was sent to the participants' phones between 18.10.2020 and 18.11.2020 and participants' informed consent was obtained.
A 43-item questionnaire form which had two sections and was prepared by the researcher in line with the literature was used in data collection. The first section questioned participants' personal characteristics (first letters of participants' names and surnames, date of birth, profession, employment status, risk of Covid-19 infection, family type, etc.), while the second section questioned the practices of following 14 rules declared by the Turkish Ministry of Health to prevent the Covid-19 pandemic (using a mask, observing the hand hygiene and social distance, etc.) and whether participants were diagnosed with Covid-19. Identity details that could help identify the participants were not questioned.
- Conditions
- COVID-19 Infection
- Keywords
- COVID-19, risk factor, symptoms, protective measures
- Medical subject headings
- COVID-19
What is being measured
The primary outcome is the main question the study is designed to answer.
Risk factors affecting the infection of Covid-19 in Turkish society
Risk factors for Covid-19 infection
Measured: Last 6 month
Secondary outcomes (1)
Difference between the protective measures taken from Covid-19 cases and healthy people
Protective measures taken during the Covid-19 Pandemic
Measured: Last 6 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Apr 2021
- Study start18 Oct 2020
- Primary completion18 Nov 2020
- Study completion25 Feb 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for COVID-19 InfectionStudies of the same condition, open and under way.
- More trials run by Istanbul University - CerrahpasaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,104 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gulbeyaz Can, Istanbul University - Cerrahpasa
- Investigators
- Gulbeyaz CAN, Prof., Principal investigator, IUC Florence Nıghtingale Nursing Faculty
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04848610
- Sponsor's protocol ID
- Covid-19 Infection
- Status last verified
- Apr 2021
- First submitted
- 12 Apr 2021
- Last updated
- 19 Apr 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of The Factors That Affect The Infection Of Covid-19 In Turkish Society
- ClinicalTrials.gov ID
- NCT04848610
- Acronym / sponsor ID
- Covid-19 Infection
- Conditions
- COVID-19 Infection
- Keywords
- COVID-19, risk factor, symptoms, protective measures
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,104 participants (actual)
- Lead sponsor
- Istanbul University - CerrahpasaUniversity, hospital or other
- Study start
- 18 Oct 2020 (actual)
- Primary completion
- 18 Nov 2020 (actual)
- Study completion
- 25 Feb 2021 (actual)
- First posted
- 19 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The number of new Coronavirus-2019 (Covid-19) cases is increasing day by day despite the warnings "Stay at home! Wear a mask! Keep social distance!". The aim of this descriptive study is to determine the risk factors that affect the Covid-19 infection in Turkey.
The online link of the form created on Google forms was sent to the participants' phones between 18.10.2020 and 18.11.2020.
Detailed description
The number of new Coronavirus-2019 (Covid-19) cases is increasing day by day despite the warnings "Stay at home! Wear a mask! Keep social distance!". The aim of this descriptive study is to determine the risk factors that affect the Covid-19 infection in Turkey.
The majority of the lands within the Republic of Turkey cover Anatolia, while a minor part covers Thrace, the southeast extension of the Balkan Peninsula. The population of Turkey is 83,154,997. Based on the natural, human and financial characteristics, the country consists of seven regions: Mediterranean, Eastern Anatolia, Aegean, Southeastern Anatolia, Central Anatolia, Marmara, and Black Sea. The majority of the population lives in the Marmara Region. The online link of the form created on Google forms was sent to the participants' phones between 18.10.2020 and 18.11.2020 and participants' informed consent was obtained.
A 43-item questionnaire form which had two sections and was prepared by the researcher in line with the literature was used in data collection. The first section questioned participants' personal characteristics (first letters of participants' names and surnames, date of birth, profession, employment status, risk of Covid-19 infection, family type, etc.), while the second section questioned the practices of following 14 rules declared by the Turkish Ministry of Health to prevent the Covid-19 pandemic (using a mask, observing the hand hygiene and social distance, etc.) and whether participants were diagnosed with Covid-19. Identity details that could help identify the participants were not questioned.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The majority of the lands within the Republic of Turkey cover Anatolia, while a minor part covers Thrace, the southeast extension of the Balkan Peninsula. The population of Turkey is 83,154,997. Based on the natural, human and financial characteristics, the country consists of seven regions: Mediterranean, Eastern Anatolia, Aegean, Southeastern Anatolia, Central Anatolia, Marmara, and Black Sea. The majority of the population lives in the Marmara Region. Many people from seven regions of Turkey were invited to participate in the study, only 1264 individuals participated. The data of 1104 people who agreed to participate and completed the assessment form thoroughly were included. Data of 160 were excluded owing to answering certain items twice.
Key inclusion criteria (3 listed)
- Being over the age of 18
- Be in good mental and mental health
- To be able to read and write
Key exclusion criteria (1 listed)
- Being under the age of 18
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Risk factors affecting the infection of Covid-19 in Turkish society
Time frame: Last 6 month
Risk factors for Covid-19 infection
1 secondary outcome
Difference between the protective measures taken from Covid-19 cases and healthy people
Time frame: Last 6 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Apr 2021.
Related trials for COVID-19 Infection
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gulbeyaz CAN, Prof. principal investigator
IUC Florence Nıghtingale Nursing Faculty
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of COVID-19 Infection, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Risk factors affecting the infection of Covid-19 in Turkish society (time frame: Last 6 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2021.